Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of Amniotic Suspension Allograft (ASA) in Patients With Osteoarthritis of the Knee

NCT04636229 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.

NCT NCT04636229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04636229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of Amniotic Suspension Allograft (ASA) in Patients With Osteoarthritis of the Knee
Lead sponsor
Organogenesis
Phase
Phase 3
Overall status
Completed
Start date
December 14, 2020
Completion date
August 19, 2025
Enrollment
516 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis